Wall Street expects a year-over-year increase in earnings on higher revenues when Insmed (INSM) reports results for the ...

Investors in Insmed Inc (Symbol: INSM) saw new options become available today, for the December 2024 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” third-quarter 2024 investor letter. A copy of the letter can be downloaded here.

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Global equity markets continued ...

Insmed Incorporated reported $144.6M in Q4 Brinsupri sales, 4.6% TAM penetration, and a 2026 Arikayce market trial expansion.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Insmed Incorporated (“Insmed” or “the Company”) (NASDAQ: INSM) ...

Insmed Inc. Annual cash flow by MarketWatch. View INSM net cash flow, operating cash flow, operating expenses and cash dividends.

Insmed Incorporated (NASDAQ:INSM) shares are trading higher after the company released topline results from its Phase 3 ARISE study of ARIKAYCE in patients with newly diagnosed or recurrent ...

Investors in Insmed Inc (Symbol: INSM) saw new options begin trading today, for the July 2024 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the ...